Literature DB >> 25394235

The molecular basis of Clostridium difficile disease and host response.

Rana E El Feghaly1, Hansraj Bangar, David B Haslam.   

Abstract

PURPOSE OF REVIEW: Clostridium difficile infection (CDI) ranges from asymptomatic colonization to severe colitis and death. The physiologic and molecular mechanisms determining disease outcome are thus far poorly understood. Here, we review recent advances in the relationship between host response to infection and disease outcome. Furthermore, we review recent studies on the relationship between intestinal microbial ecology and pathogenesis of CDI. RECENT
FINDINGS: Severe CDI is characterized by toxin-induced epithelial injury and marked intestinal inflammation. Recent studies demonstrate that systemic markers of inflammation correlate with disease outcome. Peripheral neutrophil count, C-reactive protein, and proinflammatory cytokines are elevated in patients with severe disease as compared with asymptomatic controls. Furthermore, fecal inflammatory biomarkers are better predictors of disease severity and diarrhea persistence than C. difficile abundance. A landmark study reported higher than 80% success rate of fecal microbiota transplantation for treatment of recurrent CDI. The commensal microbes responsible for C. difficile protection, and the molecular basis by which microbial ecology impacts disease outcome, are under active investigation.
SUMMARY: Under conditions of altered microbial ecology, C. difficile incites epithelial injury and marked intestinal inflammation, the primary determinant of disease outcome. Restoration of a diverse intestinal microbial population by fecal microbiota transplantation attenuates disease and prevents recurrence by mechanisms that are yet to be fully elucidated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25394235     DOI: 10.1097/MOG.0000000000000131

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  12 in total

1.  Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis.

Authors:  Byoung-Mo Koo; George Kritikos; Jeremiah D Farelli; Horia Todor; Kenneth Tong; Harvey Kimsey; Ilan Wapinski; Marco Galardini; Angelo Cabal; Jason M Peters; Anna-Barbara Hachmann; David Z Rudner; Karen N Allen; Athanasios Typas; Carol A Gross
Journal:  Cell Syst       Date:  2017-02-08       Impact factor: 10.304

2.  Colonoscopic-Guided Pinch Biopsies in Mice as a Useful Model for Evaluating the Roles of Host and Luminal Factors in Colonic Inflammation.

Authors:  David C Montrose; Xi K Zhou; Erin M McNally; Erika Sue; Hanhan Wang; Ryohei Nishiguchi; Akanksha Verma; Olivier Elemento; Kenneth W Simpson; Peiying Yang; Timothy Hla; Andrew J Dannenberg
Journal:  Am J Pathol       Date:  2018-09-28       Impact factor: 4.307

Review 3.  Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.

Authors:  Yongrong Zhang; Hanping Feng
Journal:  Pathog Dis       Date:  2016-04-04       Impact factor: 3.166

Review 4.  An update on antibody-based immunotherapies for Clostridium difficile infection.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Clin Exp Gastroenterol       Date:  2016-08-01

5.  Leptin receptor q223r polymorphism influences neutrophil mobilization after Clostridium difficile infection.

Authors:  S Jose; M M Abhyankar; A Mukherjee; J Xue; H Andersen; D B Haslam; R Madan
Journal:  Mucosal Immunol       Date:  2018-01-24       Impact factor: 7.313

6.  Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice.

Authors:  Jiani Wang; Christina Ortiz; Lindsey Fontenot; Riya Mukhopadhyay; Ying Xie; Xinhua Chen; Hanping Feng; Charalabos Pothoulakis; Hon Wai Koon
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 7.759

Review 7.  Statin use and the risk of Clostridium difficile infection: a systematic review with meta-analysis.

Authors:  Raseen Tariq; Dhruvika Mukhija; Arjun Gupta; Siddharth Singh; Darrell S Pardi; Sahil Khanna
Journal:  Infect Drug Resist       Date:  2018-03-13       Impact factor: 4.003

8.  Cysteine Protease-Mediated Autocleavage of Clostridium difficile Toxins Regulates Their Proinflammatory Activity.

Authors:  Yongrong Zhang; Shan Li; Zhiyong Yang; Lianfa Shi; Hua Yu; Rosangela Salerno-Goncalves; Ashley Saint Fleur; Hanping Feng
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-02-09

9.  The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses.

Authors:  Gabrio Bassotti; Andrea Marchegiani; Pierfrancesco Marconi; Katia Fettucciari
Journal:  Microbiologyopen       Date:  2020-07-12       Impact factor: 3.139

10.  Peptidoglycan analysis reveals that synergistic deacetylase activity in vegetative Clostridium difficile impacts the host response.

Authors:  Héloise Coullon; Aline Rifflet; Richard Wheeler; Claire Janoir; Ivo G Boneca; Thomas Candela
Journal:  J Biol Chem       Date:  2020-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.